1.36 +0.00 (0.00%)
SPPI
Stock Details
Last Trade:1.36 Change:+0.00 (0.00%) Prev Close:1.36 Open: 1.48 Days Range:1.33 – 1.48 52 Week Range: 0.46 - 3.35 Volume:126181 P/E: N/AEPS:-1.15
View AllRecent Alerts 12/02/08
Recent Alert on 10/29/08 at 9:57am
Allergan (AGN) and Spectrum Pharmaceuticals (SPPI) Announce Collaboration Agreement for Apaziquone (EOquin(R))
Allergan (AGN) and Spectrum Pharmaceuticals (SPPI) Announce Collaboration Agreement for Apaziquone (EOquin(R))
Allergan (NYSE: AGN) and Spectrum Pharmaceuticals (Nasdaq: SPPI) announced signing an exclusive collaboration for the development and commercialization of apaziquone, an antineoplastic agent currently being investigated for the treatment of... Read More
Recent Alert on 10/29/08 at 9:57am
Allergan (AGN) and Spectrum Pharmaceuticals (SPPI) Announce Collaboration Agreement for Apaziquone (EOquin(R))
Allergan (AGN) and Spectrum Pharmaceuticals (SPPI) Announce Collaboration Agreement for Apaziquone (EOquin(R))
Recent Alert on 10/29/08 at 9:57am
Allergan (AGN) and Spectrum Pharmaceuticals (SPPI) Announce Collaboration Agreement for Apaziquone (EOquin(R))
Allergan (AGN) and Spectrum Pharmaceuticals (SPPI) Announce Collaboration Agreement for Apaziquone (EOquin(R))
Recent Alert on 09/09/08 at 9:18am
Morgan Joseph Initiates Coverage on Spectrum Pharmaceuticals (SPPI)
Morgan Joseph Initiates Coverage on Spectrum Pharmaceuticals (SPPI)
View AllRecent Press Releases
Press Release on 12/01/08 at 7:00am
Spectrum Pharmaceuticals Announces ZEVALIN sBLA Granted Priority Review by the FDA; Target Decision (PDUFA) Date of April 2, 2009
Spectrum Pharmaceuticals Announces ZEVALIN sBLA Granted Priority Review by the FDA; Target Decision (PDUFA) Date of April 2, 2009
Press Release on 12/01/08 at 7:00am
Spectrum Pharmaceuticals to Host Conference Call Detailing ZEVALIN Joint Venture and Near-Term Strategy
Spectrum Pharmaceuticals to Host Conference Call Detailing ZEVALIN Joint Venture and Near-Term Strategy
View AllRecent SEC Filings
No Recent SEC Filings Available